Que Liu, MD, PhD

Director, Clinical Development
Isis Pharmaceuticals Inc.
Papers:
FP17-3 ISIS Ptp-1BRx, a Novel Protein Tyrosine Phosphatase (PTP-1B) Antisense Inhibitor, Improves Both Insulin and Leptin Action and Increases HMW Adiponectin Levels in Obese Subjects